BRC Therapeutics (BRC), a pharmaceutical company developing proprietary therapeutics for neurological and inflammatory diseases, tod ...

Fannin Partners and Allterum Therapeutics, Inc. are pleased to announce that Brian Wipke, Ph.D., an accomplished immunologist and drug discovery and development leader with more than 20 years of ...

In collaboration with Roche, one of the world’s largest biotechnology companies, industrial technology company Emerson has developed a digital library of modalities for faster deployment and use of ...

Gene therapies promise life-saving medicines, but their uptake has been slow and recent investments in the modality and supporting technologies have lagged across the biopharmaceutical industry. Dr.

Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Drug Discovery & Development Virtual Event on February ...

In this webinar, we will present the latest advances and challenges facing researchers focused on new and emerging modalities in drug discovery. Topics will include targeted protein degradation, ...

Global pharma leaders, scientists, and innovators will gather in San Francisco from Nov 03–05, 2025, to explore transformative sessions. InnoPharm-2025 is a global stage where science meets innovation ...

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...

aProximate TM PTCs maintain high expression of key transporters involved in drug handling, including megalin and cubilin, making them ideal for studying drug transporters and drug interactions with ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...